Stocks › LQDA
Liquidia Corp
LQDA·Nasdaq·
United States·USD
$25.91
-1.73 (-6.26%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
LQDA
Liquidia Corp · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
LQDAS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of LQDA by members of U.S. Congress · 0 on record
No congressional trades in LQDA on record.
Whale Activity
Position changes in LQDA reported for 2026-06-30 by 10 tracked institutional filers
- Increased5
- New0
- Held0
- Decreased1
- Closed1
- No prior filing3
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 10.8M | $860.2M | increased |
| FINDELL CAPITAL MANAGEMENT LLC | 3.5M | $279.2M | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.1M | $250.3M | increased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.5M | $122.2M | increased |
| D. E. Shaw & Co., Inc. | 1.3M | $101.1M | increased |
| TWO SIGMA INVESTMENTS, LP | 266.8K | $21.3M | decreased |
| Seven Fleet Capital Management LP | 256.6K | $20.5M | — |
| RENAISSANCE TECHNOLOGIES LLC | 232.4K | $18.5M | increased |
| AWH Capital, L.P. | 73.0K | $5.8M | — |
| Citadel Advisors LLC | 0 | $0 | closed |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by LQDA insiders, by quarter · Form 4
Recent Insider Transactions
686 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| SINGH RAMANDirector · Director | Sale | −8,468 | $66.16 | $560K | Sep 14, 2026 | Form 4 ↗ |
| SINGH RAMANDirector · Director | Sale | −9,024 | $68.62 | $619K | Sep 11, 2026 | Form 4 ↗ |
| Krepp SarahChief Human Resource Officer | Sale | −274 | $67.76 | $19K | Sep 1, 2026 | Form 4 ↗ |
| Adair JasonChief Business Officer | Sale | −41.8K | $69.09 | $2.9M | Aug 21, 2026 | Form 4 ↗ |
| Adair JasonChief Business Officer | Sale | −31.8K | $69.09 | $2.2M | Aug 21, 2026 | Form 4 ↗ |
| Rielly-Gauvin KatherineDirector · Director | Sale | −18.4K | $72.23 | $1.3M | Aug 20, 2026 | Form 4 ↗ |
| Rielly-Gauvin KatherineDirector · Director | Sale | −36.8K | $74.99 | $2.8M | Aug 19, 2026 | Form 4 ↗ |
| Saggar RajeevChief Medical Officer | Sale | −50.0K | $74.06 | $3.7M | Aug 19, 2026 | Form 4 ↗ |
| Saggar RajeevChief Medical Officer | Sale | −29.5K | $76.84 | $2.3M | Aug 17, 2026 | Form 4 ↗ |
| Boyle DanaChief Accounting Officer | Sale | −1,600 | $87.53 | $140K | Jul 27, 2026 | Form 4 ↗ |
| Adair JasonChief Business Officer | Sale | −688 | $87.53 | $60K | Jul 27, 2026 | Form 4 ↗ |
| Bloch Stephen MDirector · Director | Sale | −96.4K | $89.44 | $8.6M | Jul 23, 2026 | Form 4 ↗ |
| Bloch Stephen MDirector · Director | Sale | −3,600 | $90.71 | $327K | Jul 23, 2026 | Form 4 ↗ |
| Bloch Stephen MDirector · Director | Sale | −48.0K | $88.65 | $4.3M | Jul 22, 2026 | Form 4 ↗ |
| Bloch Stephen MDirector · Director | Sale | −37.4K | $87.70 | $3.3M | Jul 22, 2026 | Form 4 ↗ |
| Bloch Stephen MDirector · Director | Sale | −14.6K | $89.24 | $1.3M | Jul 22, 2026 | Form 4 ↗ |
| Bloch Stephen MDirector · Director | Sale | −74.4K | $79.98 | $6.0M | Jul 21, 2026 | Form 4 ↗ |
| Bloch Stephen MDirector · Director | Sale | −556 | $80.66 | $45K | Jul 21, 2026 | Form 4 ↗ |
| Bloch Stephen MDirector · Director | Sale | −3,596 | $79.55 | $286K | Jul 20, 2026 | Form 4 ↗ |
| Krepp SarahChief Human Resource Officer | Sale | −7,306 | $71.52 | $523K | Jul 13, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding LQDA · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF iShares Trust | 4.2M | $337.5M | 0.30% | Jun 30, 2026 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 2.3M | $180.1M | 0.01% | Jun 30, 2026 |
| iShares Russell 2000 ETF iShares Trust | 1.8M | $144.4M | 0.17% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 771.4K | $64.9M | 0.19% | Jul 31, 2026 |
| FULLERTHALER BEHAVIORAL SMALL-CAP GROWTH Capitol Series Trust | 812.8K | $64.8M | 1.05% | Jun 30, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 805.9K | $64.3M | 0.07% | Jun 30, 2026 |
| iShares Russell 2000 Growth ETF iShares Trust | 651.5K | $51.9M | 0.34% | Jun 30, 2026 |
| State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF SPDR SERIES TRUST | 643.8K | $51.3M | 0.30% | Jun 30, 2026 |
| iShares S&P Small-Cap 600 Growth ETF iShares Trust | 631.3K | $50.3M | 0.61% | Jun 30, 2026 |
| T. Rowe Price New Horizons Fund, Inc. | 521.7K | $41.6M | 0.28% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list LQDA's shares (CUSIP 53635D202), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- BKB Growth Investments, LLCSCHEDULE 13G/A · passive (13G) · 716.3K shares0.8%
Aug 14, 2026 · ↗ - PD Joint Holdings, LLC Series 2016-ASCHEDULE 13G/A · passive (13G) · 198.4K shares0.2%
Aug 14, 2026 · ↗ - Paul B ManningSCHEDULE 13G/A · passive (13G) · 4.9M shares6.5%
Aug 14, 2026 · ↗ - Farallon Capital F5 Master I, L.P.SCHEDULE 13G/A · passive (13G) · 0 shares0.0%
Aug 4, 2026 · ↗ - Farallon Capital (AM) Investors, L.P.SCHEDULE 13G/A · passive (13G) · 0 shares0.0%
Aug 4, 2026 · ↗ - Farallon Capital Offshore Investors II, L.P.SCHEDULE 13G/A · passive (13G) · 0 shares0.0%
Aug 4, 2026 · ↗ - Four Crossings Institutional Partners V, L.P.SCHEDULE 13G/A · passive (13G) · 0 shares0.0%
Aug 4, 2026 · ↗ - Farallon Capital Institutional Partners III, L.P.SCHEDULE 13G/A · passive (13G) · 0 shares0.0%
Aug 4, 2026 · ↗ - Farallon Capital Institutional Partners II, L.P.SCHEDULE 13G/A · passive (13G) · 0 shares0.0%
Aug 4, 2026 · ↗ - Farallon Capital Institutional Partners, L.P.SCHEDULE 13G/A · passive (13G) · 0 shares0.0%
Aug 4, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming Liquidia Corp as client
No lobbying filings found naming Liquidia Corp as the client.
Government Contracts
Federal awards to Liquidia Corp · USAspending
No federal contract awards found for Liquidia Corp.
U.S. Patents
Recent USPTO applications naming Liquidia Corp
No USPTO patent applications found for Liquidia Corp.
Annual Financials
From LQDA's 10-K filings · XBRL
No annual XBRL figures on record for LQDA. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No stock splits in LQDA's price history.
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 8.01, 9.01Other eventsSep 30, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsSep 3, 2026
EDGAR ↗ - 8-K · Items 2.02, 8.01, 9.01Results of operations · Other eventsAug 12, 2026
EDGAR ↗ - 8-K · Items 5.07, 9.01Shareholder voteJun 17, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsJun 8, 2026
EDGAR ↗ - 8-K · Items 2.02, 8.01, 9.01Results of operations · Other eventsMay 11, 2026
EDGAR ↗
About Liquidia Corp
From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersMORRISVILLE, NC
IncorporatedDE
SEC CIK0001819576 ↗
